Correction to: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer

doi:10.1093/procel/pwaf036

Correction to: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancerJ. Protein&Cell, 2026, 17(1): 89-89. DOI: 10.1093/procel/pwaf036

Citation:

Correction to: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancerJ. Protein&Cell, 2026, 17(1): 89-89. DOI: 10.1093/procel/pwaf036

Citation:

Correction to: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancerJ. Protein&Cell, 2026, 17(1): 89-89. DOI: 10.1093/procel/pwaf036

Correction to: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer

Abstract

FullText(HTML)

References (0)

Cited By

Correction to: Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer

Catalog

Export File

Citation

Format

Content